A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
Autor: | Bugarski-Kirola, D., Wang, A., Abi-Saab, D., Blättler, T. |
---|---|
Zdroj: | In European Neuropsychopharmacology July 2014 24(7):1024-1036 |
Databáze: | ScienceDirect |
Externí odkaz: |